THC Detection Windows: Drug Testing Facts and Variables

This article is for informational purposes only. Cannabis research is an evolving field with significant regulatory barriers to clinical trials. Consult a healthcare provider before using cannabinoid products.

By Take Hemp Gummies Research Desk | Last verified: July 2026

The Question

How long does THC remain detectable in your body after consumption, and what factors determine whether a drug test will return positive or negative? This page examines the scientific evidence on THC detection windows across the three most common testing matrices—urine, blood, and hair—while exploring the biological and product-related variables that cause detection times to vary widely between individuals.

The Mechanism: How THC Is Metabolized and Detected

THC Absorption and Lipophilicity

When THC (delta-9-tetrahydrocannabinol) enters the body through inhalation or ingestion, it crosses the blood-brain barrier and binds to CB1 and CB2 receptors in the central and peripheral nervous systems. Critically, THC is highly lipophilic—it dissolves readily in fat but poorly in water. This property is central to understanding detection windows. Because THC accumulates in adipose (fat) tissue, it is slowly released back into the bloodstream over hours to days, extending the period during which it can be detected in biological matrices.

Metabolic Pathways and 11-OH-THC

The liver metabolizes THC primarily through cytochrome P450 enzymes (CYP3A4 and CYP2C9). The first major metabolite is 11-hydroxy-THC (11-OH-THC), which is pharmacologically active and crosses the blood-brain barrier more readily than THC itself. This metabolite is then oxidized to 11-nor-9-carboxy-THC (THC-COOH), the primary inactive metabolite that is excreted in urine and feces. THC-COOH is the target analyte in most urine drug tests because of its stability and longer detection window compared to unconverted THC.

Individual Variability in Clearance

Several factors influence how quickly individuals metabolize and clear THC. Genetic polymorphisms in CYP3A4 and CYP2C9 affect enzyme activity; body mass index and total body fat content determine THC sequestration; hydration status influences urinary concentration; and frequency of use leads to cannabinoid accumulation in chronic consumers. Older adults, individuals with hepatic or renal impairment, and those taking CYP3A4 inhibitors (e.g., grapefruit, certain medications) may experience prolonged detection windows.

Current Evidence

Urine Testing: Most Common Matrix, Variable Cutoffs

Urine immunoassay remains the most widely used drug screening method due to low cost and non-invasive collection. Standard federal workplace cutoff thresholds in the United States are 50 ng/mL for initial screening and 15 ng/mL for confirmatory testing (gas chromatography-mass spectrometry). A landmark study by Huestis et al. (2005) in the Journal of Analytical Toxicology tracked urinary THC-COOH elimination in 13 occasional smokers and 14 chronic smokers following controlled inhalation.

Occasional users cleared detectable metabolite (≥15 ng/mL) within 3–4 days; chronic users remained positive for 21–67 days. The study noted that passive exposure and residual oral cavity THC do not produce detectable urine levels above the 15 ng/mL federal threshold.

Cone et al. (1992) examined 25 heavy cannabis users in a controlled environment, finding that urinary THC-COOH remained detectable at ≥20 ng/mL for an average of 33 days after last use. Wide individual variation (range: 3–77 days) was attributed to differences in body fat content, baseline kidney function, and prior accumulation from repeated dosing. Critically, this study demonstrated that THC-COOH can be reabsorbed in the enterohepatic circulation, prolonging detection.

Blood Testing: Shorter Window, Active Metabolite Detection

Blood testing detects unconverted THC and 11-OH-THC, which are pharmacologically relevant but clear more rapidly than urinary metabolites. Huestis et al. (1992) measured plasma THC and metabolites in 8 occasional smokers using GC-MS, finding peak THC concentrations of 50–200 ng/mL immediately post-inhalation, declining to <5 ng/mL within 3–12 hours in most subjects. THC-COOH in plasma remained detectable (≥1 ng/mL) for 24–48 hours in occasional users.

A 2016 systematic review by Desrosiers et al. in Clinical Chemistry examined 42 published studies on cannabinoid detection across matrices. For blood, the authors found that THC is typically undetectable beyond 6–8 hours post-inhalation in occasional users, but may persist 24–48 hours in chronic users due to continuous mobilization from adipose reserves. Oral ingestion produces lower peak plasma concentrations but more prolonged detection (12–24 hours) due to slower absorption and extended hepatic first-pass metabolism.

Hair Testing: Longest Window, Incorporation Mechanism

Hair follicle testing detects cannabinoids through incorporation into hair protein during growth, not through systemic circulation. This mechanism allows detection of THC use over extended periods—typically 90 days for standard 1.5-inch samples, or up to 6–12 months for longer hair segments. A study by Kintz et al. (2000) in Forensic Science International analyzed hair samples from 32 regular cannabis users, finding detectable THC concentrations (0.1–4 ng/mg) in all samples, even from subjects who had abstained for 4–6 weeks. The authors noted that hair tests cannot distinguish between active use and passive exposure, though recent use is associated with higher concentrations closer to the scalp.

Ellis et al. (2013) conducted a controlled study where 6 subjects smoked cannabis in a ventilated room, with non-smokers present. Hair samples collected from non-smoking bystanders 24 hours post-exposure showed no detectable THC, suggesting that passive inhalation does not reliably produce detectable hair levels under typical conditions. However, cannabis smoke deposition on hair surface (pre-wash) can produce false positives; most laboratories require hair washing protocols to minimize this artifact.

Dose, Frequency, and Product Formulation Effects

A 2014 observational study by Goodwin et al. in Drug and Alcohol Dependence surveyed 1,896 cannabis users regarding consumption patterns and self-reported detection windows. Median detection time in urine ranged from 3–5 days (occasional users) to 30–48 days (daily users). Notably, edible formulations (gummies, oils) produced more variable and prolonged detection windows compared to inhalation, likely due to individual variation in gastrointestinal absorption and hepatic first-pass metabolism. The study also found that higher-potency cannabis (modern flower: 15–30% THC; concentrates: 60–90% THC) correlated with longer detection windows, though the relationship was not strictly dose-dependent due to metabolic saturation.

Product Labeling and Actual THC Content

A critical practical consideration is the gap between labeled and actual THC content. A 2015 analysis by Vandrey et al. in JAMA tested 38 commercially purchased cannabis products from states with legalization. Labeled THC potency ranged 10–90%; actual potency ranged 6–83%, with significant understatement in 60% of products tested. This variability has direct implications for detection window predictions: a consumer believing they consumed 10 mg THC (based on label) may have actually consumed 5–15 mg, affecting both pharmacodynamic effects and detection duration.

Evidence Table